A Multicentre, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Individual Dose Regimens of HB0017 in Patients with Moderate-to-severe Plaque Psoriasis
BRITISH JOURNAL OF DERMATOLOGY(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要